Be part of the conversation.

Register for the 2026 SCI PFDD Meeting.

September 29, 2026
10:00 AM – 3:00 PM ET
Virtual Event
Free to Attend

Who can attend?

People Living with SCI

Caregivers &
Family Members

Healthcare
Professionals

Researchers,
Industry & Advocates

Everyone

What is PFDD?

Patient-Focused Drug Development (PFDD) is an FDA initiative that brings the voices of people living with spinal cord injury into research, clinical development, and FDA decision-making.
Learn More About PFDD →

Amplifies Patient Voices

Captures the lived experiences and priorities of the SCI community.

Informs Research & Trials

Helps researchers design studies around what matters most to patients.

Guides FDA Decisions

Patient perspectives become part of future regulatory discussions.

What to Expect

Join a collaborative virtual meeting where people living with spinal cord injury, care partners, clinicians, researchers, and advocates come together to share experiences that will help inform future research, treatment development, and regulatory decision-making.

Opening Remarks

Welcome to the meeting and learn how to participate.

Overview of Spinal Cord Injury

Overview of SCI, current challenges, and the treatment landscape.

Panel 1: Daily Life Impacts

Hear firsthand experiences about daily life with SCI.

Midday Break

Take a short break before the afternoon sessions.

Treatment Landscape

Learn about available treatments and management approaches.

Panel 2: Treatments & Priorities

Discuss treatment experiences, unmet needs, and future priorities.

Closing Remarks

Meeting highlights and next steps.

Throughout the Meeting

You'll have several opportunities to listen, share your experiences, and help guide the conversation.

Pre-recorded Testimony

Hear stories submitted by people living with spinal cord injury during the nomination process.

Live Polling

Answer polling questions throughout the meeting and see community responses in real time.

Public Comment

Share your perspective during designated public comment opportunities.